Literature DB >> 33431650

An evidence review of face masks against COVID-19.

Jeremy Howard1,2, Austin Huang3, Zhiyuan Li4, Zeynep Tufekci5, Vladimir Zdimal6, Helene-Mari van der Westhuizen7,8, Arne von Delft8,9, Amy Price10, Lex Fridman11, Lei-Han Tang12,13, Viola Tang14, Gregory L Watson15, Christina E Bax16, Reshama Shaikh17, Frederik Questier18, Danny Hernandez19, Larry F Chu10, Christina M Ramirez15, Anne W Rimoin20.   

Abstract

The science around the use of masks by the public to impede COVID-19 transmission is advancing rapidly. In this narrative review, we develop an analytical framework to examine mask usage, synthesizing the relevant literature to inform multiple areas: population impact, transmission characteristics, source control, wearer protection, sociological considerations, and implementation considerations. A primary route of transmission of COVID-19 is via respiratory particles, and it is known to be transmissible from presymptomatic, paucisymptomatic, and asymptomatic individuals. Reducing disease spread requires two things: limiting contacts of infected individuals via physical distancing and other measures and reducing the transmission probability per contact. The preponderance of evidence indicates that mask wearing reduces transmissibility per contact by reducing transmission of infected respiratory particles in both laboratory and clinical contexts. Public mask wearing is most effective at reducing spread of the virus when compliance is high. Given the current shortages of medical masks, we recommend the adoption of public cloth mask wearing, as an effective form of source control, in conjunction with existing hygiene, distancing, and contact tracing strategies. Because many respiratory particles become smaller due to evaporation, we recommend increasing focus on a previously overlooked aspect of mask usage: mask wearing by infectious people ("source control") with benefits at the population level, rather than only mask wearing by susceptible people, such as health care workers, with focus on individual outcomes. We recommend that public officials and governments strongly encourage the use of widespread face masks in public, including the use of appropriate regulation.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; masks; pandemic

Mesh:

Year:  2021        PMID: 33431650      PMCID: PMC7848583          DOI: 10.1073/pnas.2014564118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  94 in total

1.  Risk, ritual and health responsibilisation: Japan's 'safety blanket' of surgical face mask-wearing.

Authors:  Adam Burgess; Mitsutoshi Horii
Journal:  Sociol Health Illn       Date:  2012-03-23

2.  The size distribution of droplets in the exhaled breath of healthy human subjects.

Authors:  R S Papineni; F S Rosenthal
Journal:  J Aerosol Med       Date:  1997

3.  Some state vaccination laws contribute to greater exemption rates and disease outbreaks in the United States.

Authors:  W David Bradford; Anne Mandich
Journal:  Health Aff (Millwood)       Date:  2015-08       Impact factor: 6.301

4.  Testing the risk compensation hypothesis for safety helmets in alpine skiing and snowboarding.

Authors:  Michael D Scott; David B Buller; Peter A Andersen; Barbara J Walkosz; Jennifer H Voeks; Mark B Dignan; Gary R Cutter
Journal:  Inj Prev       Date:  2007-06       Impact factor: 2.399

Review 5.  Universal Motorcycle Helmet Laws to Reduce Injuries: A Community Guide Systematic Review.

Authors:  Yinan Peng; Namita Vaidya; Ramona Finnie; Jeffrey Reynolds; Cristian Dumitru; Gibril Njie; Randy Elder; Rebecca Ivers; Chika Sakashita; Ruth A Shults; David A Sleet; Richard P Compton
Journal:  Am J Prev Med       Date:  2017-06       Impact factor: 5.043

6.  Facemasks, hand hygiene, and influenza among young adults: a randomized intervention trial.

Authors:  Allison E Aiello; Vanessa Perez; Rebecca M Coulborn; Brian M Davis; Monica Uddin; Arnold S Monto
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

7.  A cluster randomised trial of cloth masks compared with medical masks in healthcare workers.

Authors:  C Raina MacIntyre; Holly Seale; Tham Chi Dung; Nguyen Tran Hien; Phan Thi Nga; Abrar Ahmad Chughtai; Bayzidur Rahman; Dominic E Dwyer; Quanyi Wang
Journal:  BMJ Open       Date:  2015-04-22       Impact factor: 2.692

Review 8.  Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review.

Authors:  Daniel P Oran; Eric J Topol
Journal:  Ann Intern Med       Date:  2020-06-03       Impact factor: 25.391

9.  Facepiece filtering respirators with exhalation valve should not be used in the community to limit SARS-CoV-2 diffusion.

Authors:  Mariachiara Ippolito; Pasquale Iozzo; Cesare Gregoretti; Giacomo Grasselli; Andrea Cortegiani
Journal:  Infect Control Hosp Epidemiol       Date:  2020-05-15       Impact factor: 3.254

Review 10.  The role of particle size in aerosolised pathogen transmission: a review.

Authors:  Jan Gralton; Euan Tovey; Mary-Louise McLaws; William D Rawlinson
Journal:  J Infect       Date:  2010-11-19       Impact factor: 6.072

View more
  254 in total

1.  June: open-source individual-based epidemiology simulation.

Authors:  Joseph Aylett-Bullock; Carolina Cuesta-Lazaro; Arnau Quera-Bofarull; Miguel Icaza-Lizaola; Aidan Sedgewick; Henry Truong; Aoife Curran; Edward Elliott; Tristan Caulfield; Kevin Fong; Ian Vernon; Julian Williams; Richard Bower; Frank Krauss
Journal:  R Soc Open Sci       Date:  2021-07-07       Impact factor: 2.963

Review 2.  COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection.

Authors:  Kevin Escandón; Angela L Rasmussen; Isaac I Bogoch; Eleanor J Murray; Karina Escandón; Saskia V Popescu; Jason Kindrachuk
Journal:  BMC Infect Dis       Date:  2021-07-27       Impact factor: 3.090

3.  What the science says about lifting mask mandates.

Authors:  Lynne Peeples
Journal:  Nature       Date:  2021-05       Impact factor: 49.962

4.  Face masks effectively limit the probability of SARS-CoV-2 transmission.

Authors:  Yafang Cheng; Nan Ma; Christian Witt; Steffen Rapp; Philipp S Wild; Meinrat O Andreae; Ulrich Pöschl; Hang Su
Journal:  Science       Date:  2021-05-20       Impact factor: 63.714

Review 5.  Safety and Reverence: How Roman Catholic Liturgy Can Respond to the COVID-19 Pandemic.

Authors:  Sergey Budaev
Journal:  J Relig Health       Date:  2021-05-24

Review 6.  The therapeutic potential of inorganic polyphosphate: A versatile physiological polymer to control coronavirus disease (COVID-19).

Authors:  Hadrian Schepler; Xiaohong Wang; Meik Neufurth; Shunfeng Wang; Heinz C Schröder; Werner E G Müller
Journal:  Theranostics       Date:  2021-04-15       Impact factor: 11.556

7.  The impact of non-pharmaceutical interventions on COVID-19 epidemic growth in the 37 OECD member states.

Authors:  Francisco Pozo-Martin; Heide Weishaar; Florin Cristea; Johanna Hanefeld; Thurid Bahr; Lars Schaade; Charbel El Bcheraoui
Journal:  Eur J Epidemiol       Date:  2021-06-10       Impact factor: 8.082

8.  Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions With Infections, Hospitalizations, and Mortality.

Authors:  Mehul D Patel; Erik Rosenstrom; Julie S Ivy; Maria E Mayorga; Pinar Keskinocak; Ross M Boyce; Kristen Hassmiller Lich; Raymond L Smith; Karl T Johnson; Paul L Delamater; Julie L Swann
Journal:  JAMA Netw Open       Date:  2021-06-01

9.  Study of Recycling Potential of FFP2 Face Masks and Characterization of the Plastic Mix-Material Obtained. A Way of Reducing Waste in Times of Covid-19.

Authors:  Cristina Crespo; Gemma Ibarz; Carlos Sáenz; Pablo Gonzalez; Sandra Roche
Journal:  Waste Biomass Valorization       Date:  2021-05-31       Impact factor: 3.703

10.  COVID-19 Containment Measures at Childcare and Schools in 19 European Countries: An Observational Study on Local, Federal and National Policies.

Authors:  Danielle E M C Jansen; Johanna P M Vervoort; Károly E Illy; Adamos Hadjipanayis
Journal:  Int J Public Health       Date:  2021-04-21       Impact factor: 3.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.